Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14

Trial Status

Recruiting3
Other6

Role Distribution

Principal Investigator9
PI Rate100%

Activity Timeline

Clinical Trials (9)

NCT06130826Phase 1Recruiting
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
Breast CarcinomaColorectal Carcinoma
PrincipalinvestigatorStart date: 2025-05-27
NCT05844306Not ApplicableActive Not Recruiting
RefleXion PET/CT Imaging Performance in Patients With Various Malignancies
Hematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm
PrincipalinvestigatorStart date: 2023-03-15
NCT05245786Early Phase 1Active Not Recruiting
An Investigational Scan (64Cu-Labeled M5A Antibody) in Combination With SOC Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer
Locally Advanced Rectal CarcinomaStage III Rectal Cancer AJCC v8Stage IIIA Rectal Cancer AJCC v8+2 more
PrincipalinvestigatorStart date: 2022-08-31
NCT05470699Not ApplicableActive Not Recruiting
RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer
Prostate Carcinoma
PrincipalinvestigatorStart date: 2022-08-29
NCT05139004Phase 1Active Not Recruiting
90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome+1 more
PrincipalinvestigatorStart date: 2022-07-19
NCT05204147Phase 1Recruiting
Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers
Advanced CancerMetastatic Cancer
PrincipalinvestigatorStart date: 2022-06-02
NCT04380831Early Phase 1Active Not Recruiting
TBI Using IMRT and Cyclophosphamide Prior to Stem Cell Transplant for the Treatment of Severe Systemic Sclerosis
Systemic Scleroderma
PrincipalinvestigatorStart date: 2022-02-24
NCT03422731Early Phase 1Active Not Recruiting
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia
PrincipalinvestigatorStart date: 2018-02-15

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteAdvanced CancerMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score5%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

Myelodysplastic SyndromesLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score5%

Norman Wolmark, MD

NSABP Foundation Inc

Related
54 trials

Shared therapeutic areas:

Colorectal CancerMetastatic CancerBreast Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Metastatic CancerColorectal Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Colorectal CancerAdvanced Cancer
Similarity Score4%

Project Leader

Ono Pharmaceutical Co., Ltd.

Related
47 trials

Shared therapeutic areas:

Colorectal CancerMyelodysplastic Syndromes
Similarity Score4%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Scleroderma, Systemic
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (9)

Showing 9 of 9 trials

NCT06287944Phase 1PrincipalInvestigator

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome
Recruiting
NCT06130826Phase 1PrincipalInvestigator

Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer

Breast CarcinomaColorectal Carcinoma
Recruiting
NCT05844306Not ApplicablePrincipalInvestigator

RefleXion PET/CT Imaging Performance in Patients With Various Malignancies

Hematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm
Active Not Recruiting
NCT05245786Early Phase 1PrincipalInvestigator

An Investigational Scan (64Cu-Labeled M5A Antibody) in Combination With SOC Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer

Locally Advanced Rectal CarcinomaStage III Rectal Cancer AJCC v8Stage IIIA Rectal Cancer AJCC v8+2 more
Active Not Recruiting
NCT05470699Not ApplicablePrincipalInvestigator

RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer

Prostate Carcinoma
Active Not Recruiting
NCT05139004Phase 1PrincipalInvestigator

90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome

Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome+1 more
Active Not Recruiting
NCT05204147Phase 1PrincipalInvestigator

Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers

Advanced CancerMetastatic Cancer
Recruiting
NCT04380831Early Phase 1PrincipalInvestigator

TBI Using IMRT and Cyclophosphamide Prior to Stem Cell Transplant for the Treatment of Severe Systemic Sclerosis

Systemic Scleroderma
Active Not Recruiting
NCT03422731Early Phase 1PrincipalInvestigator

Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy

Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia
Active Not Recruiting

All 9 trials loaded